Use of bibloc and monobloc oral appliances in obstructive sleep apnoea: a multicentre, randomized, blinded, parallel-group equivalence trial

Göran Isacsson, Eva Nohlert, Anette M C Fransson, Anna Bornefalk-Hermansson, Eva Wiman Eriksson, Eva Ortlieb, Livia Trepp, Anna Avdelius, Magnus Sturebrand, Clara Fodor, Thomas List, Mohamad Schumann, Åke Tegelberg, Göran Isacsson, Eva Nohlert, Anette M C Fransson, Anna Bornefalk-Hermansson, Eva Wiman Eriksson, Eva Ortlieb, Livia Trepp, Anna Avdelius, Magnus Sturebrand, Clara Fodor, Thomas List, Mohamad Schumann, Åke Tegelberg

Abstract

Background: The clinical benefit of bibloc over monobloc appliances in treating obstructive sleep apnoea (OSA) has not been evaluated in randomized trials. We hypothesized that the two types of appliances are equally effective in treating OSA.

Objective: To compare the efficacy of monobloc versus bibloc appliances in a short-term perspective.

Patients and methods: In this multicentre, randomized, blinded, controlled, parallel-group equivalence trial, patients with OSA were randomly assigned to use either a bibloc or a monobloc appliance. One-night respiratory polygraphy without respiratory support was performed at baseline, and participants were re-examined with the appliance in place at short-term follow-up. The primary outcome was the change in the apnoea-hypopnea index (AHI). An independent person prepared a randomization list and sealed envelopes. Evaluating dentist and the biomedical analysts who evaluated the polygraphy were blinded to the choice of therapy.

Results: Of 302 patients, 146 were randomly assigned to use the bibloc and 156 the monobloc device; 123 and 139 patients, respectively, were analysed as per protocol. The mean changes in AHI were -13.8 (95% confidence interval -16.1 to -11.5) in the bibloc group and -12.5 (-14.8 to -10.3) in the monobloc group. The difference of -1.3 (-4.5 to 1.9) was significant within the equivalence interval (P = 0.011; the greater of the two P values) and was confirmed by the intention-to-treat analysis (P = 0.001). The adverse events were of mild character and were experienced by similar percentages of patients in both groups (39 and 40 per cent for the bibloc and monobloc group, respectively).

Limitations: The study shows short-term results with a median time from commencing treatment to the evaluation visit of 56 days and long-term data on efficacy and harm are needed to be fully conclusive.

Conclusion: In a short-term perspective, both appliances were equivalent in terms of their positive effects for treating OSA and caused adverse events of similar magnitude.

Trial registration: Registered with ClinicalTrials.gov (#NCT02148510).

Figures

Figure 1.
Figure 1.
The bibloc (left) and monobloc (right) appliances.
Figure 2.
Figure 2.
Trial profile. Population: ITT = intention-to-treat, PP = per protocol.

References

    1. Qaseem A., Holty J.E., Owens D.K., Dallas P., Starkey M. and Shekelle P; Clinical Guidelines Committee of the American College of Physicians (2013)Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 159, 471–483.
    1. Randerath W.J., et al. ; European Respiratory Society task force on non-CPAP therapies in sleep apnoea. (2011)Non-CPAP therapies in obstructive sleep apnoea. The European Respiratory Journal, 37, 1000–1028.
    1. Lettieri C.J., Paolino N., Eliasson A.H., Shah A.A. and Holley A.B (2011)Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea. Journal of Clinical Sleep Medicine, 7, 439–445.
    1. Serra-Torres S., Bellot-Arcís C., Montiel-Company J.M., Marco-Algarra J. and Almerich-Silla J.M (2016)Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: a systematic review. The Laryngoscope, 126, 507–514.
    1. Isacsson G., Fodor C. and Sturebrand M (2017)Obstructive sleep apnea treated with custom-made bibloc and monobloc oral appliances: a retrospective comparative study. Sleep and Breathing, 21, 93–100.
    1. George P.T. (1992)A new instrument for functional appliance bite registration. Journal of Clinical Orthodontics, 26, 721–723.
    1. Johns M.W. (1991)A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 14, 540–545.
    1. Korpe L., Lundgren J. and Dahlström L (2013)Psychometric evaluation of a Swedish version of the functional outcomes of sleep questionnaire, FOSQ. Acta Odontologica Scandinavica, 71, 1077–1084.
    1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L. and Garofalo E (1998)Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. The Journal of the American Medical Association, 280, 1831–1836.
    1. Ahrens A., McGrath C. and Hägg U (2011)A systematic review of the efficacy of oral appliance design in the management of obstructive sleep apnoea. European Journal of Orthodontics, 33, 318–324.
    1. Medical Advisory Secretariat. (2009)Oral appliances for obstructive sleep apnea: an evidence-based analysis. Ontario Health Technology Assessment Series, 9, 1–51.
    1. Fransson A.M., Tegelberg A., Leissner L., Wenneberg B. and Isacsson G (2003)Effects of a mandibular protruding device on the sleep of patients with obstructive sleep apnea and snoring problems: a 2-year follow-up. Sleep and Breathing, 7, 131–141.
    1. Johal A., Fleming P.S., Manek S. and Marinho V.C (2015)Mandibular advancement splint (MAS) therapy for obstructive sleep apnoea—an overview and quality assessment of systematic reviews. Sleep and Breathing, 19, 1101–1108.
    1. Bloch K.E., Iseli A., Zhang J.N., Xie X., Kaplan V., Stoeckli P.W. and Russi E.W (2000)A randomized, controlled crossover trial of two oral appliances for sleep apnea treatment. American Journal of Respiratory and Critical Care Medicine, 162, 246–251.
    1. Vecchierini M.F., Léger D., Laaban J.P., Putterman G., Figueredo M., Levy J., Vacher C., Monteyrol P.J. and Philip P (2008)Efficacy and compliance of mandibular repositioning device in obstructive sleep apnea syndrome under a patient-driven protocol of care. Sleep Medicine, 9, 762–769.
    1. Vecchierini M.F., et al. ; ORCADES investigators. (2016)A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome: the ORCADES study. Sleep Medicine, 19, 131–140.
    1. Vanderveken O.M., Dieltjens M., Wouters K., De Backer W.A., Van de Heyning P.H. and Braem M.J (2013)Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax, 68, 91–96.
    1. Dieltjens M., Braem M.J., Vroegop A.V.M.T., Wouters K., Verbraecken J.A., De Backer W.A., Van de Heyning P.H. and Vanderveken O.M (2013)Objectively measured vs self-reported compliance during oral appliance therapy for sleep-disordered breathing. Chest, 144, 1495–1502.
    1. Lim J., Lasserson T.J., Fleetham J. and Wright J (2006)Oral appliances for obstructive sleep apnoea. Cochrane Database Systematic Review, 1:CD004435.
    1. Hamoda M.M., Kohzuka Y. and Almeida F.R (2018)Oral appliances for the management of OSA: an updated review of the literature. Chest, 153, 544–553.
    1. Sunnergren O., Broström A. and Svanborg E (2011)Soft palate sensory neuropathy in the pathogenesis of obstructive sleep apnea. The Laryngoscope, 121, 451–456.
    1. Fransson A. (2003)A mandibular protruding device in obstructive sleep apnea and snoring. Swedish Dental Journal Supplement, 163: 1–49.
    1. Bartolucci M.L., Bortolotti F., Raffaelli E., D’Antò V., Michelotti A. and Alessandri Bonetti G (2016)The effectiveness of different mandibular advancement amounts in OSA patients: a systematic review and meta-regression analysis. Sleep and Breathing, 20, 911–919.
    1. Anitua E., Durán-Cantolla J., Almeida G.Z. and Alkhraisat M.H (2017)Minimizing the mandibular advancement in an oral appliance for the treatment of obstructive sleep apnea. Sleep Medicine, 34, 226–231.

Source: PubMed

3
Se inscrever